
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Verantos, a regulatory-grade electronic health record (EHR)-based studies provider, announced commercial availability of its solution for real-world-evidence (RWE) study implementation. Verantos designed a framework to leverage both structured and unstructured EHR data for clinical insight with the use of artificial intelligence to generate RWE.
Read the full release






